Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-30 @ 11:33 PM
Study NCT ID:
NCT05465733
Status:
UNKNOWN
Last Update Posted:
2022-07-20
First Post:
2022-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-line Replacement Maintenance of Envafolimab in Advanced NSCLC
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
No.XJTU1AF2022LSK-263
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None